mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
3e-05 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
4e-05 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
8e-05 |
mRNA |
Zebularine |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
8e-05 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
GSK1120212 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0002 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0002 |
mRNA |
Oxaliplatin |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0003 |